[1] |
HEWITT D B, BROWN Z J, PAWLIK T M. Surgical management of intrahepatic cholangiocarcinoma[J]. Expert Rev Anticancer Ther, 2022, 22(1):27-38. DOI: 10.1080/14737140.2022.1999809.
|
[2] |
SPOSITO C, DROZ DIT BUSSET M, VIRDIS M,et al. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma:a review[J]. Eur J Surg Oncol, 2022, 48(1):150-159. DOI: 10.1016/j.ejso.2021.08.009.
|
[3] |
WU L, TSILIMIGRAS D I, PAREDES A Z,et al. Trends in the incidence,treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA:facility type is associated with margin status,use of lymphadenectomy and overall survival[J]. World J Surg, 2019, 43(7):1777-1787. DOI: 10.1007/s00268-019-04966-4.
|
[4] |
EL-DIWANY R, PAWLIK T M, EJAZ A. Intrahepatic cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2019, 28(4):587-599. DOI: 10.1016/j.soc.2019.06.002.
|
[5] |
NAVARRO J G, LEE J H, KANG I,et al. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma:do all require lymph node dissection?[J]. HPB, 2020, 22(10):1411-1419. DOI: 10.1016/j.hpb.2020.01.009.
|
[6] |
ZHANG X F, CHEN Q Y, KIMBROUGH C W,et al. Lymphadenectomy for intrahepatic cholangiocarcinoma:has nodal evaluation been increasingly adopted by surgeons over Time? A national database analysis[J]. J Gastrointest Surg, 2018, 22(4):668-675. DOI: 10.1007/s11605-017-3652-2.
|
[7] |
KIZY S, ALTMAN A M, MARMOR S,et al. Surgical resection of lymph node positive intrahepatic cholangiocarcinoma may not improve survival[J]. HPB:Oxford, 2019, 21(2):235-241. DOI: 10.1016/j.hpb.2018.08.006.
|
[8] |
SWEIGERT P J, EGUIA E, JANJUA H,et al. Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?[J]. Surg Open Sci, 2020, 2(3):107-112. DOI: 10.1016/j.sopen.2020.04.003.
|
[9] |
ZHANG X F, LV Y, WEISS M,et al. Should utilization of lymphadenectomy vary according to morphologic subtype of intrahepatic cholangiocarcinoma?[J]. Ann Surg Oncol, 2019, 26(7):2242-2250. DOI: 10.1245/s10434-019-07336-5.
|
[10] |
KIM S H, HAN D H, CHOI G H,et al. Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma:a propensity score-matched study[J]. J Gastrointest Surg, 2019, 23(3):538-544. DOI: 10.1007/s11605-018-3899-2.
|
[11] |
ZHANG X F, XUE F, DONG D H,et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis[J]. Ann Surg, 2021, 274(6):e1187-1195. DOI: 10.1097/SLA.0000000000003788.
|
[12] |
ZHOU R, LU D H, LI W D,et al. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis[J]. HPB, 2019, 21(7):784-792. DOI: 10.1016/j.hpb.2018.12.011.
|
[13] |
BAGANTE F, SPOLVERATO G, CUCCHETTI A,et al. Defining when to offer operative treatment for intrahepatic cholangiocarcinoma:a regret-based decision curves analysis[J]. Surgery, 2016, 160(1):106-117. DOI: 10.1016/j.surg.2016.01.023.
|
[14] |
|
[15] |
TSUJI T, HIRAOKA T, KANEMITSU K,et al. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma[J]. Surgery, 2001, 129(4):401-407. DOI: 10.1067/msy.2001.111873.
|
[16] |
|